Help us: Donate
Follow us on:
×

Menu

Back

Tag: Antibody

Erase bad cells
A group of researchers has developed a delivery system that identifies senescent cells and injects them with a deadly compound. This offers a potential solution to the problem of targeted delivery of senolytics [1]. Cellular senescence has been implicated in numerous aging-related disorders, including fibrosis, diabetes, cancer, and Alzheimer's. Today, senolytics, drugs that remove senescent...
Alzheimer's disease
Until now, it was unclear as to whether drugs that clear amyloid, which accumulate in the brain during aging and accompany diseases such as Alzheimer's, have any influence over cognitive decline. Previous studies have aimed to find this out, but results have been inconclusive due to study designs, hard-to-interpret data, and other issues that muddy...
COVID-19 Therapeutics Roadmap
The COVID-19 pandemic is dominating the news as countries around the world work hard to control the spread of the disease. Social distancing can help "flatten the curve" and prevent the overload of healthcare systems; however, there is a large percentage of people who develop serious complications after getting the virus. The global community is...
Today, we would like to share with you the talk given by Kelsey Moody, CEO of Biotech Company Ichor, at the recent Ending Age-Related Diseases: Investment Prospects & Advances in Research conference in New York City. In this talk, Kelsey discusses Ichor's protein engineering platform, how Ichor has used it, and Ichor's plans for using it to...
Researchers at the University of California San Diego School of Medicine have shown that they can block inflammation in mice, thereby protecting them from liver disease and hardening of the arteries while increasing their healthy lifespan. The study, published in the journal Nature, shows that inflammation can be blocked using a naturally occurring antibody that...